ARCHIVES

Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 3 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

JRB Wins $3.6 Million Support contract

November 29, 1974

Pediatric Rule Makes FDA Consider Defining Tumors By Molecular Target.

August 31, 2001

House Appropriations For NCI Identical (So Far) To White House Request; Slight Increase for NIH

June 24, 1988

M.D. Anderson Sells Itself As Research Base For CCOPs

August 8, 1986

In Brief: Board Subcommittee Meetings On Comprehensive Centers Postponed; FDA Committee Uncharted

March 10, 1978

In Brief: Senate Cancer Coalition Hearing On Tamoxifin Planned for May 11; Bresnick Leads AACR

May 6, 1994